Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Cash from Operations (2023 - 2026)

Compass Therapeutics' Cash from Operations history spans 4 years, with the latest figure at 17269000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations fell 30.75% to 17269000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 53204000.0, a 20.44% decrease, with the full-year FY2025 number at 49143000.0, down 9.56% from a year prior.
  • Cash from Operations hit 17269000.0 in Q1 2026 for Compass Therapeutics, down from 13254000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for CMPX hit a ceiling of 5922000.0 in Q3 2023 and a floor of 17269000.0 in Q1 2026.
  • Historically, Cash from Operations has averaged 11683461.54 across 4 years, with a median of 11832000.0 in 2025.
  • The widest YoY moves for Cash from Operations: up 25.84% in 2024, down 86.61% in 2024.
  • Tracing CMPX's Cash from Operations over 4 years: stood at 12354000.0 in 2023, then rose by 25.84% to 9162000.0 in 2024, then tumbled by 44.66% to 13254000.0 in 2025, then crashed by 30.29% to 17269000.0 in 2026.
  • Business Quant data shows Cash from Operations for CMPX at 17269000.0 in Q1 2026, 13254000.0 in Q4 2025, and 10849000.0 in Q3 2025.